Skip to main content
Erschienen in: Wiener klinische Wochenschrift 15-16/2016

01.08.2016 | original article

Changes in the before and after thyroxine treatment levels of adipose tissue, leptin, and resistin in subclinical hypothyroid patients

verfasst von: Gulhan Akbaba, MD, Assoc. Prof. Dilek Berker, MD, Assoc. Prof. Serhat Isık, MD, Mazhar Muslum Tuna, MD, Suha Koparal, MD, Murat Vural, MD, Assoc. Prof. Fatma Meric Yılmaz, MD, Canan Topcuoglu, MD, Prof. Serdar Guler, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2016

Einloggen, um Zugang zu erhalten

Summary

Background

Subclinical hypothyroidism (SH) occurs when serum thyroid stimulating hormone (TSH) concentrations are raised and serum thyroid hormone concentrations are normal. The effect of SH on the proinflammatory adipose cytokine releasing visceral adipose tissue (VAT) is not clear. The aim of this study is to identify the difference between the pre and posttreatment levels of VAT, leptin, and resistin in SH patients.

Methods

There were 51 SH patients and 43 age- and gender-matched healthy subjects included in the study. Thyroid functions, biochemical tests, leptin, resistin, and visceral and subcutaneous fat measurements were made. The measurements were repeated in the SH group in the third month following L-thyroxin treatment.

Results

Initially, high sensitivity C-reactive protein, carotid artery intima-media thickness (mm), leptin, and resistin levels were significantly higher in the SH group compared to the controls, while the other parameters were similar. While no correlation was observed between TSH levels and adipokines, a positive correlation was detected between waist circumference and leptin levels (r = 0.549, p < 0.01). Visceral adipose tissue was positively correlated to age, waist circumference, and leptin levels, but negatively correlated to free thyroxin (T4) levels (r = 0.419, p = 0.009; r = 0.794, p < 0.01; r = 0.515, p < 0.01 and r = − 0.416, p = 0.009, respectively). A significant decrease was observed in VAT volume, leptin, and resistin levels of SH patients following levothyroxine treatment.
Conclusion
The reduced VAT volume, leptin, and resistin levels in SH patients following treatment may support the idea that TSH affects adipose tissue functions.
Literatur
1.
Zurück zum Zitat Zamboni M, Armellini F, Turcato E, et al. Effect of regain of body weight on regional body fat distribution: comparison between pre- and postmenopausal obese women. Obes Res. 1996;4:555–60.CrossRefPubMed Zamboni M, Armellini F, Turcato E, et al. Effect of regain of body weight on regional body fat distribution: comparison between pre- and postmenopausal obese women. Obes Res. 1996;4:555–60.CrossRefPubMed
2.
Zurück zum Zitat Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273–82.CrossRefPubMed Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273–82.CrossRefPubMed
3.
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–9.CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–9.CrossRefPubMed
4.
Zurück zum Zitat Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005;44:794–9.CrossRefPubMed Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005;44:794–9.CrossRefPubMed
6.
Zurück zum Zitat Rodondi N, Bauer DC, Cappola AR, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol. 2008;52:1152–9.CrossRefPubMedPubMedCentral Rodondi N, Bauer DC, Cappola AR, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol. 2008;52:1152–9.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Rodondi N, den Elzen WP, Bauer DC, Thyroid Studies Collaboration, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.CrossRefPubMedPubMedCentral Rodondi N, den Elzen WP, Bauer DC, Thyroid Studies Collaboration, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Fox CS, Pencina MJ, D’Agostino RB, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008;168:587–92.CrossRefPubMed Fox CS, Pencina MJ, D’Agostino RB, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008;168:587–92.CrossRefPubMed
9.
Zurück zum Zitat Hsieh CJ, Wang PW, Wang ST, et al. Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol (Oxf). 2002;57:29–34.CrossRef Hsieh CJ, Wang PW, Wang ST, et al. Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol (Oxf). 2002;57:29–34.CrossRef
10.
Zurück zum Zitat Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem. 2004;93:491–6.CrossRefPubMed Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem. 2004;93:491–6.CrossRefPubMed
11.
Zurück zum Zitat Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol. 1997;137:659–63.CrossRefPubMed Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol. 1997;137:659–63.CrossRefPubMed
12.
Zurück zum Zitat Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997;7:407–9.CrossRefPubMed Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997;7:407–9.CrossRefPubMed
13.
Zurück zum Zitat Iglesias P, Alvarez FP, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003;59:621–9.CrossRef Iglesias P, Alvarez FP, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003;59:621–9.CrossRef
14.
Zurück zum Zitat Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab. 1997;82:1632–4.PubMed Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab. 1997;82:1632–4.PubMed
15.
Zurück zum Zitat Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K, Saruta T. Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol (Oxf). 1998;48:299–302.CrossRef Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K, Saruta T. Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol (Oxf). 1998;48:299–302.CrossRef
16.
Zurück zum Zitat Diekman MJ, Romijn JA, Endert E, Sauerwein H, Wiersinga WM. Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women. Thyroid. 1998;8:1081–6.CrossRefPubMed Diekman MJ, Romijn JA, Endert E, Sauerwein H, Wiersinga WM. Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women. Thyroid. 1998;8:1081–6.CrossRefPubMed
17.
Zurück zum Zitat Pinkney JH, Goodrick SJ, Katz J, et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf). 1998;49:583–8. Pinkney JH, Goodrick SJ, Katz J, et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf). 1998;49:583–8.
18.
Zurück zum Zitat Botella-Carretero JI, Alvarez-Blasco F, Sancho J, Escobar-Morreale HF. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid. 2006;16:397–402.CrossRefPubMed Botella-Carretero JI, Alvarez-Blasco F, Sancho J, Escobar-Morreale HF. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid. 2006;16:397–402.CrossRefPubMed
19.
Zurück zum Zitat Oge A, Bayraktar F, Saygili F, Guney E, Demir S. TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients. Endocr J. 2005;52:213–7.CrossRefPubMed Oge A, Bayraktar F, Saygili F, Guney E, Demir S. TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients. Endocr J. 2005;52:213–7.CrossRefPubMed
20.
Zurück zum Zitat Krassas GE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Kaltsas T. Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. J Endocrinol Invest. 2006;29:606–12.CrossRefPubMed Krassas GE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Kaltsas T. Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. J Endocrinol Invest. 2006;29:606–12.CrossRefPubMed
21.
Zurück zum Zitat Westerink J, van der Graaf Y, Faber DR, Visseren FL; SMART study group. The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur J Clin Invest. 2011;41:159–66.CrossRefPubMed Westerink J, van der Graaf Y, Faber DR, Visseren FL; SMART study group. The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur J Clin Invest. 2011;41:159–66.CrossRefPubMed
22.
Zurück zum Zitat Korkmaz L, Sahin S, Akyuz AR, et al. Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med Princ Pract. 2013;22:42–6.CrossRefPubMed Korkmaz L, Sahin S, Akyuz AR, et al. Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism. Med Princ Pract. 2013;22:42–6.CrossRefPubMed
23.
Zurück zum Zitat Yildiz BO, Aksoy DY, Harmanci A, et al. Effects of L-thyroxine therapy on circulating leptin and adiponectin levels in subclinical hypothyroidism: a prospective study. Arch Med Res. 2013;44:317–20.CrossRefPubMed Yildiz BO, Aksoy DY, Harmanci A, et al. Effects of L-thyroxine therapy on circulating leptin and adiponectin levels in subclinical hypothyroidism: a prospective study. Arch Med Res. 2013;44:317–20.CrossRefPubMed
25.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
26.
Zurück zum Zitat Cappola AR, Ladenson PW: Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88:2438–44.CrossRefPubMed Cappola AR, Ladenson PW: Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88:2438–44.CrossRefPubMed
27.
Zurück zum Zitat McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011;2:837–43.CrossRef McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011;2:837–43.CrossRef
28.
Zurück zum Zitat Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring). 2010;18:890–6.CrossRef Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring). 2010;18:890–6.CrossRef
29.
Zurück zum Zitat Weiss TW, Arnesen H, Troseid M, et al. Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. Wien Klin Wochenschr. 2011;123:650–4.CrossRefPubMed Weiss TW, Arnesen H, Troseid M, et al. Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. Wien Klin Wochenschr. 2011;123:650–4.CrossRefPubMed
30.
Zurück zum Zitat Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond). 2009;33:1001–6.CrossRef Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond). 2009;33:1001–6.CrossRef
32.
Zurück zum Zitat Asvold BO, Bjoro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med. 2008;168:855–60.CrossRefPubMed Asvold BO, Bjoro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med. 2008;168:855–60.CrossRefPubMed
33.
Zurück zum Zitat Bruckert E, Giral P, Chadarevian R, Turpin G. Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. J Cardiovasc Risk. 1999;6:327–31.CrossRefPubMed Bruckert E, Giral P, Chadarevian R, Turpin G. Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. J Cardiovasc Risk. 1999;6:327–31.CrossRefPubMed
34.
Zurück zum Zitat Moon MK, Hong ES, Lim JA, et al. Associations between thyroid hormone levels and regional fat accumulation in euthyroid men. Eur J Endocrinol. 2013;168:805–10.CrossRefPubMed Moon MK, Hong ES, Lim JA, et al. Associations between thyroid hormone levels and regional fat accumulation in euthyroid men. Eur J Endocrinol. 2013;168:805–10.CrossRefPubMed
35.
Zurück zum Zitat Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007;3:CD003419.PubMed Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007;3:CD003419.PubMed
36.
Zurück zum Zitat Gunes F, Asik M, Temiz A, et al. Serum H-FABP levels in patients with hypothyroidism. Wien Klin Wochenschr. 2014;126:727–33.CrossRefPubMed Gunes F, Asik M, Temiz A, et al. Serum H-FABP levels in patients with hypothyroidism. Wien Klin Wochenschr. 2014;126:727–33.CrossRefPubMed
37.
Zurück zum Zitat Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004;89:2099–106.CrossRefPubMed Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004;89:2099–106.CrossRefPubMed
38.
Zurück zum Zitat Ghasemi M, Mousavi SA, Rezvanian H, Asadi B, Khorvash F, Fatehi F. Carotid intima-media thickness in subclinical hypothyroidism. Int J Stroke. 2010;5:131–2.CrossRefPubMed Ghasemi M, Mousavi SA, Rezvanian H, Asadi B, Khorvash F, Fatehi F. Carotid intima-media thickness in subclinical hypothyroidism. Int J Stroke. 2010;5:131–2.CrossRefPubMed
39.
Zurück zum Zitat Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52:89–94.CrossRefPubMed Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52:89–94.CrossRefPubMed
40.
Zurück zum Zitat Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005;63:203–6.CrossRef Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005;63:203–6.CrossRef
41.
Zurück zum Zitat Aksoy DY, Cinar N, Harmanci A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Med Sci Monit. 2013;19:210–5.CrossRefPubMedPubMedCentral Aksoy DY, Cinar N, Harmanci A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Med Sci Monit. 2013;19:210–5.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Peleg RK, Efrati S, Benbassat C, Fygenzo M, Golik A. The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid. 2008;18:825–30.CrossRefPubMed Peleg RK, Efrati S, Benbassat C, Fygenzo M, Golik A. The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid. 2008;18:825–30.CrossRefPubMed
43.
Zurück zum Zitat Sharma R, Sharma TK, Kaushik GG, Sharma S, Vardey SK, Sinha M. Subclinical hypothyroidism and its association with cardiovascular risk factors. Clin Lab. 2011;57:719–24.PubMed Sharma R, Sharma TK, Kaushik GG, Sharma S, Vardey SK, Sinha M. Subclinical hypothyroidism and its association with cardiovascular risk factors. Clin Lab. 2011;57:719–24.PubMed
44.
Zurück zum Zitat Iglesias P, Diez JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine. 2007;40:61–70.CrossRefPubMed Iglesias P, Diez JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine. 2007;40:61–70.CrossRefPubMed
45.
Zurück zum Zitat Ozata M, Ozisik G, Bingol N, Corakci A, Gundogan MA. The effects of thyroid status on plasma leptin levels in women. J Endocrinol Invest. 1998;21:337–41.CrossRefPubMed Ozata M, Ozisik G, Bingol N, Corakci A, Gundogan MA. The effects of thyroid status on plasma leptin levels in women. J Endocrinol Invest. 1998;21:337–41.CrossRefPubMed
46.
Zurück zum Zitat Sesmilo G, Casamitjana R, Halperin I, Gomis R, Vilardell E. Role of thyroid hormones on serum leptin levels. Eur J Endocrinol. 1998;139:428–30.CrossRefPubMed Sesmilo G, Casamitjana R, Halperin I, Gomis R, Vilardell E. Role of thyroid hormones on serum leptin levels. Eur J Endocrinol. 1998;139:428–30.CrossRefPubMed
47.
Zurück zum Zitat Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties, J Immunol. 2005;174:5789–95.CrossRefPubMed Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties, J Immunol. 2005;174:5789–95.CrossRefPubMed
48.
Zurück zum Zitat Filkova M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009;133:157–70.CrossRefPubMed Filkova M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009;133:157–70.CrossRefPubMed
49.
Zurück zum Zitat Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Spontaneous diurnal thyrotropin secretion is enhanced in proportion to circulating leptin in obese premenopausal women. J Clin Endocrinol Metab. 2005;90:6185–91.CrossRefPubMed Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Spontaneous diurnal thyrotropin secretion is enhanced in proportion to circulating leptin in obese premenopausal women. J Clin Endocrinol Metab. 2005;90:6185–91.CrossRefPubMed
Metadaten
Titel
Changes in the before and after thyroxine treatment levels of adipose tissue, leptin, and resistin in subclinical hypothyroid patients
verfasst von
Gulhan Akbaba, MD
Assoc. Prof. Dilek Berker, MD
Assoc. Prof. Serhat Isık, MD
Mazhar Muslum Tuna, MD
Suha Koparal, MD
Murat Vural, MD
Assoc. Prof. Fatma Meric Yılmaz, MD
Canan Topcuoglu, MD
Prof. Serdar Guler, MD
Publikationsdatum
01.08.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0865-9

Weitere Artikel der Ausgabe 15-16/2016

Wiener klinische Wochenschrift 15-16/2016 Zur Ausgabe